Ribocure Pharmaceuticals
高管
查看带有其 16 名主要高管的组织结构图
Ribocure Pharmaceuticals 搜索最多的简介
- Li-Ming Gan, Chief Executive Officer & Board Member
- Zicai Liang, Chairman of the Board
- Sara Svedlund, Head of Ribocure Clinic & Senior Medical Director
创建提醒
跟踪 Ribocure Pharmaceuticals 的高管变动
生物技术
Ribocure Pharmaceuticals 拥有 2,317 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Evommune 刚刚宣布为 115 筹款数百万美元。 (公布2024十一月4号).
- AgomAb Therapeutics 刚刚宣布为 89 筹款数百万美元。 (公布2024十月29号).
- Seaport Therapeutics 刚刚宣布为 225 筹款数百万美元。 (公布2024十月25号).
生物技术 行业的其他推荐联系人
消息
Ribocure Pharmaceuticals 的最新新闻稿
- Ribo and Pheiron enter strategic collaboration for AI-assisted drug development of RNA therapeutics-News-Suzhou Ribo Life Science Co., Ltd
- Ribo Presents First-In-Class FXI Targeting siRNA Drug RBD4059 Phase Ⅰ Clinical Data At ESC Congress 2024-News-Suzhou Ribo Life Science Co., Ltd
- Innovating for a Healthier Tomorrow: Ribo Role in Transforming Liver Disease Treatment with siRNA-News-Suzhou Ribo Life Science Co., Ltd
- Boehringer Ingelheim partners with Ribo to develop new treatments for people with liver diseases-News-Suzhou Ribo Life Science Co., Ltd
- Ribo and Qilu Announce Licensing Agreement for siRNA Therapeutic Targeting PCSK9-News-Suzhou Ribo Life Science Co., Ltd
- Ribo is to Present the Latest Research Data on Two Investigational siRNA Drugs under Development at EASL2023-News-Suzhou Ribo Life Science Co., Ltd
- Suzhou Ribo announces the first siRNA-based FXI targeting anti-thrombotic agent (RBD4059) to receive HREC approval for first-in-human study in Australia-News-Suzhou Ribo Life Science Co., Ltd
- Ribo Announces Successful Passing EU GMP Audit.-News-Suzhou Ribo Life Science Co., Ltd
- Ribo Announces China CDE Approval of Clinical Trial Application of RBD7022 First-In-Human Clinical Trial in China for Treatment of Hyperlipidemia.-News-Suzhou Ribo Life Science Co., Ltd
- Ribocure Pharmaceuticals Moves Into GoCo Clinic - Putting North Europe in the Spotlight Within Oligonucleotide Therapeutics-News-Suzhou Ribo Life Science Co., Ltd
- View more press releases Close
通过电子邮件
